Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (4): 55-61.doi: 10.6040/j.issn.1673-3770.0.2023.146

• Original Article • Previous Articles    

Correlation analysis of gene expression profile of matrix metalloproteinases and their inhibitors in laryngeal squamous cell carcinoma and clinicopathological features

NI Rongsheng1, SHEN Xiaohui2, GAO Xia2   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, Nanjing Jiangbei Hospital Affiliated to Nantong University, Nanjing 210044, Jiangsu, China 2. Department of Otorhinolaryngology & Head and Neck Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China
  • Published:2024-07-09

PDF (PC)

126

Abstract: Objective The study aimed to discover the gene expression profiles of the matrix metalloproteinases(MMPs)family and tissue inhibitors of matrix metalloproteinases(TIMPs)in laryngeal squamous cell carcinoma(LSCC), to analyze the genes most relevant to LSCC, and finally clarify their relationship with clinicopathological features. Methods Twenty-eight patients with LSCC were studied. In four patients, genes in the MMPs family and TIMPs that are up-regulated or down-regulated simultaneously were detected by a gene chip containing the entire human genome. The gene chip results were verified by reverse transcription-polymerase chain reaction(RT-PCR)and western blot in the other 24 patients. The correlation between the expression of the proteins encoded by the genes and the clinicopathological characteristics of the patients were investigated. Results The gene chip analysis revealed 14 differentially expressed genes of MMPs family between LSCC and adjacent normal cells. Of these, four genes were up-regulated, four were down-regulated, and the remaining six were up-regulated in some patients and down-regulated in others. No genes were consistently up- or down-regulated in the four patients. In contrast, all TIMPs were down-regulated between LSCC and adjacent normal cells. The TIMP4 gene was down-regulated in all four patients. RT-PCR and western blot results showed that the TIMP4 gene and protein was poorly expressed, respectively, in LSCC tissue. Western blot also showed that the expression of TIMP4 protein was correlated with lymph node metastasis. Conclusion To our knowledge, this is the first description of the expression profile of MMPs and TIMPs in LSCC. The expression of TIMP4 protein was associated with the clinicopathological features of LSCC. Future studies may further confirm TIMP4 protein as a predictor of the survival of patients with LSCC and/or a potential therapeutic target of LSCC.

Key words: Gene chip, Laryngeal squamous cell carcinoma, Matrix metalloproteinase, Tissue inhibitor of metalloproteinase

CLC Number: 

  • R739.65
[1] Yin DH, Guo L, Li SS, et al. Clinical significance of neuropilin-2 expression in laryngeal squamous cell carcinoma[J]. Am J Otolaryngol, 2020, 41(4): 102540. doi:10.1016/j.amjoto.2020.102540
[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi:10.3322/caac.21492
[3] Rivière D, Mancini J, Santini L, et al. Lymph-node metastasis following total laryngectomy and total pharyngolaryngectomy for laryngeal and hypopharyngeal squamous cell carcinoma: frequency, distribution and risk factors[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2018, 135(3): 163-166. doi:10.1016/j.anorl.2017.11.008
[4] Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer[J]. CA Cancer J Clin, 2017, 67(1): 31-50. doi:10.3322/caac.21386
[5] 黄恒丰, 马鲲鹏, 杨迪, 等. MiR-181b-5P和EPB41L3蛋白在喉癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 41-46. doi:10.6040/j.issn.1673-3770.0.2021.502 HUANG Hengfeng, MA Kunpeng, YANG Di, et al. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carci-noma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46. doi:10.6040/j.issn.1673-3770.0.2021.502
[6] Wu YY, Zhang YL, Zheng XW, et al. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis[J]. Mol Cancer, 2020, 19(1): 99. doi:10.1186/s12943-020-01215-4
[7] Olivares-Urbano MA, Griñán-Lisón C, Zurita M, et al. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: a pilot study[J]. J Cell Mol Med, 2020, 24(1): 139-148. doi:10.1111/jcmm.14671
[8] 裴雪艳, 王琰. 侵袭性伪足和MMP-14在肿瘤发病机制中的研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 129-134. doi: 10.6040/j.issn.1673-3770.0.2019.604 PEI Xueyan, WANG Yan. Progress in the research on the roles of invadopodia and metalloproteinase-14 in tumorigenesis and cancer development[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 129-134. doi: 10.6040/j.issn.1673-3770.0.2019.604
[9] Sala M, Ros M, Saltel F. A complex and evolutive character: two face aspects of ECM in tumor progression[J]. Front Oncol, 2020, 10: 1620. doi:10.3389/fonc.2020.01620
[10] Yuzhalin AE, Lim SY, Kutikhin AG, et al. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis[J]. Biochim Biophys Acta Rev Cancer, 2018, 1870(2): 207-228. doi:10.1016/j.bbcan.2018.09.002
[11] Kaczorowska A, Miękus N, Stefanowicz J, et al. Selected matrix metalloproteinases(MMP-2, MMP-7)and their inhibitor(TIMP-2)in adult and pediatric cancer[J]. Diagnostics, 2020, 10(8): 547. doi:10.3390/diagnostics10080547
[12] Neophytou CM, Panagi M, Stylianopoulos T, et al. The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities[J]. Cancers, 2021, 13(9): 2053. doi:10.3390/cancers13092053
[13] Levi N, Papismadov N, Solomonov I, et al. The ECM path of senescence in aging: components and modifiers[J]. FEBS J, 2020, 287(13): 2636-2646. doi:10.1111/febs.15282
[14] Melendez-Zajgla J, del Pozo L, Ceballos G, et al. Tissue inhibitor of metalloproteinases-4. The road less traveled[J]. Mol Cancer, 2008, 7: 85. doi:10.1186/1476-4598-7-85
[15] Lambert E, Dassé E, Haye B, et al. TIMPs as multifacial proteins[J]. Crit Rev Oncol Hematol, 2004, 49(3): 187-198. doi:10.1016/j.critrevonc.2003.09.008
[16] Peeney D, Fan Y, Nguyen T, et al. Matrisome-associated gene expression patterns correlating with TIMP2 in cancer[J]. Sci Rep, 2019, 9(1): 20142. doi:10.1038/s41598-019-56632-3
[17] Simonova OA, Kuznetsova EB, Tanas AS, et al. Abnormal hypermethylation of CpG dinucleotides in promoter regions of matrix metalloproteinases genes in breast cancer and its relation to epigenomic subtypes and HER2 overexpression[J]. Biomedicines, 2020, 8(5): 116. doi:10.3390/biomedicines8050116
[18] Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment[J]. Cell, 2010, 141(1): 52-67. doi:10.1016/j.cell.2010.03.015
[19] Quintero-Fabián S, Arreola R, Becerril-Villanueva E, et al. Role of matrix metalloproteinases in angiogenesis and cancer[J]. Front Oncol, 2019, 9: 1370. doi:10.3389/fonc.2019.01370
[20] Zou MY, Zhang C, Sun Y, et al. Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma[J]. Acta Oncol, 2022, 61(4): 505-515. doi:10.1080/0284186X.2021.2009564
[21] Ma LJ, Li W, Zhang X, et al. Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays[J]. Arch Med Res, 2009, 40(2): 114-123. doi:10.1016/j.arcmed.2008.12.005
[22] Koskivirta I, Rahkonen O, Mäyränpää M, et al. Tissue inhibitor of metalloproteinases 4(TIMP4)is involved in inflammatory processes of human cardiovascular pathology[J]. Histochem Cell Biol, 2006, 126(3): 335-342. doi:10.1007/s00418-006-0163-8
[23] Pullen NA, Anand M, Cooper PS, et al. Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma[J]. J Neurooncol, 2012, 106(3): 461-471. doi:10.1007/s11060-011-0691-5
[24] Ripley D, Tunuguntla R, Susi L, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and-4 in normal ovary and ovarian carcinoma[J]. Int J Gynecol Cancer, 2006, 16(5): 1794-1800. doi:10.1111/j.1525-1438.2006.00714.x
[25] Tunuguntla R, Ripley D, Sang QX, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and-4 in benign endometrium and endometrial cancer[J]. Gynecol Oncol, 2003, 89(3): 453-459. doi:10.1016/s0090-8258(03)00077-5
[26] Boufraqech M, Zhang LS, Nilubol N, et al. Lysyl oxidase(LOX)transcriptionally regulates SNAI2 expression and TIMP4 secretion in human cancers[J]. Clin Cancer Res, 2016, 22(17): 4491-4504. doi:10.1158/1078-0432.CCR-15-2461
[27] Rorive S, Lopez XM, Maris C, et al. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas[J]. Mod Pathol, 2010, 23(10): 1418-1428. doi:10.1038/modpathol.2010.136
[28] Bister V, Skoog T, Virolainen S, et al. Increased expression of matrix metalloproteinases-21 and-26 and TIMP-4 in pancreatic adenocarcinoma[J]. Mod Pathol, 2007, 20(11): 1128-1140. doi:10.1038/modpathol.3800956
[29] Hagemann T, Gunawan B, Schulz M, et al. mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas[J]. Eur J Cancer, 2001, 37(15): 1839-1846. doi:10.1016/s0959-8049(01)00215-5
[30] Lizarraga F, Espinosa M, Maldonado V, et al. Tissue inhibitor of metalloproteinases-4 is expressed in cervical cancer patients[J]. Anticancer Res, 2005, 25(1B): 623-627
[1] WU Bin, ZHOU Jingchun. Single cell sequencing analysis of RPN2 expression pattern in laryngeal squamous cell carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 1-11.
[2] WANG Kaijian, CHEN Xuesheng, WANG Wei. A meta-analysis of the correlation between platelet-lymphocyte ratio and prognosis of laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 67-73.
[3] ZHANG Shihan, LIU Hongbing. Effect of matrix metalloproteinase on tissue remodeling in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 116-123.
[4] ZHANG Yonghong, ZHANG Hui, WANG Caihua, YANG Xinxin, WU Yungang, ZHAO Yufeng, PANG Taizhong, LI Xiaoyu. Construction of an immune-associated gene prognostic model and screening of targeted molecular drugs for laryngeal squamous cell carcinoma based on the TCGA database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 54-62.
[5] LIU Yong, YUAN Cunli, CAO Hui, ZHENG Chengcai, CHAO Fang, XU Fenglei. CHD1L promotes proliferation, invasion and metastasis of laryngeal squamous cell carcinoma cells by EMT [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 32-39.
[6] MU Tingting, YANG Yujuan. Research progress of IL-36 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 114-118.
[7] FAN Yiyan, ZHANG Xiaolin, LIU Xiuzhen, YIN Jingjing, YUAN Jin, WANG Yanfei, CHEN Jun. Expression and clinical significance of CPS1 in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 72-76.
[8] CHEN Huijun, SONG Shenghua, DONG Weida, ZHOU Han. Prognostic role of preoperative fibrinogen levels in patients with laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(2): 110-114.
[9] LIU Dongmei, LI Yang, SONG Jike, GUO Dadong, MA Xianzhen, BI Hongsheng. Gene expression profile of lenses after vitrectomy and silicone oil tamponade co-treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 95-98.
[10] WANG Kuirong, RAO Lihua, LI Zhuan, DUAN Bingzhi. Association between Helicobacter pylori and laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 38-42.
[11] ZHANG Mingde, ZHANG Zuping, YU Xuemin, WEI Yanhong, YUAN Ying. RASSF2A methylation in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 64-67.
[12] ZHU Xiaocheng, QIAN Xiaoyun, GU Yajun, SHEN Xiaohui, SONG Panpan, LI Hui, GAO Xia. Expression and clinical value of MGMT and EGFR in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 68-72.
[13] LI Junying. Effects of rosuvastatin combined with fenofibrate therapy on vascular endothelial function retinopathy diabetic retinopathy patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 72-75.
[14] LI Xue-sheng, QIAN　Jin， LI Hou-en， LI Jin-rang. A review of tissue remodeling in chronic rhino-sinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 84-86.
[15] LIU Fang1, LAI Jian-xin1, LI Rui-yu1, LI Guan-zhen2. Th17/Treg cell ratio in the peripheral circμlation of human laryngeal squamous cell carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 4-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd